Showing results (411-420 of 837) with videos related to
Sort By:
Pageof 84
Free Radical Biology & Medicine|September 30, 2004
Ascorbic acid in nasal and tracheobronchial airway lining fluidsBettina C Schock, John Koostra, Sunye Kwack, et al.Blood|July 17, 2009
Safety and immunologic effects of IL-15 administration in nonhuman primatesCarolina Berger, Michael Berger, Robert C Hackman, et al.Clinical Therapeutics|November 25, 2010
Safety and tolerability of lersivirine, a nonnucleoside reverse transcriptase inhibitor, during a 28-day, randomized, placebo-controlled, Phase I clinical study in healthy male volunteersJohn Davis, Frances Hackman, Marie-Noella Ndongo, et al.Pediatric Research|February 14, 2014
Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadismJohanna Känsäkoski, Rainer Fagerholm, Eeva-Maria Laitinen, et al.Annals of Plastic Surgery|August 13, 2016
Miniplates Versus Reconstruction Bars for Oncologic Free Fibula Flap Mandible ReconstructionSaif Al-Bustani, Grace Kim Austin, Emily Cohn Ambrose, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 26, 1998
Lung injury induced by alloreactive Th1 cells is characterized by host-derived mononuclear cell inflammation and activation of alveolar macrophagesJ G Clark, D K Madtes, R C Hackman, et al.The Laryngoscope|October 17, 2018
Radiographic muscle invasion not a recurrence predictor in HPV-associated oropharyngeal squamous cell carcinomaZainab Farzal, Eugenie Du, Eunice Yim, et al.Antimicrobial Agents and Chemotherapy|September 4, 2008
Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrationsKelly Dooley, Charles Flexner, Judith Hackman, et al.AIDS (London, England)|September 26, 2009
Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patientsGerd Fätkenheuer, Schlomo Staszewski, Andreas Plettenburg, et al.Urology|February 20, 2004
Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancerRalph W deVere White, Robert M Hackman, Stephanie E Soares, et al.Pageof 84